INNPF (InnoCan Pharma) Current Accrued Expense : $0.48 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Current Accrued Expense?

InnoCan Pharma's Current Accrued Expense for the quarter that ended in Dec. 2024 was $0.48 Mil.

InnoCan Pharma's quarterly Current Accrued Expense stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.48 Mil).

InnoCan Pharma's annual Current Accrued Expense increased from Dec. 2022 ($0.32 Mil) to Dec. 2023 ($0.46 Mil) and increased from Dec. 2023 ($0.46 Mil) to Dec. 2024 ($0.48 Mil).

InnoCan Pharma Current Accrued Expense Historical Data

The historical data trend for InnoCan Pharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Current Accrued Expense Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

0.38

0.32

0.46

0.48

InnoCan Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Current Accrued Expense	Get a 7-Day Free Trial															0.46	-	-	-	0.48

InnoCan Pharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

InnoCan Pharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.